DNLI Earnings

Quarterly EPS
$-0.59
Q2 2024
$-0.63
Q3 2024
$-0.67
Q4 2024
$-0.78
Q1 2025
$-0.72
Q2 2025
$-0.74
Q3 2025
$-0.73
Q4 2025
$-0.69
Q1 2026
Latest RevenueN/A
Latest Net Income-128447000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.690-128447000+11.5%
Q4 2025-$0.730-128549000-9.0%
Q3 2025-$0.740-126902000-17.5%
Q2 2025-$0.720-124119000-22.0%
Q1 2025-$0.780-132970000-14.7%
Q4 2024-$0.670-114753000+22.1%
Q3 2024-$0.630-107192000-100.0%+12.5%
Q2 2024-$0.590-99026000-100.0%-144.0%
Q1 2024-$0.680-101802000
Q4 2023-$0.860-119473000
Q3 2023-$0.721.3M-99353000
Q2 2023$1.34294.1M183.4M
Denali Therapeutics (DNLI) — Earnings